Neuralink’s Clinical Trial: technical breakdown, key moments and clinical context

Caption & verification basis: English manual captions (Official video playback, English caption track, official description, and primary Neuralink disclosures).

If you've been living with quadriplegia from a spinal cord injury (SCI) or with amyotrophic lateral sclerosis (ALS), you may qualify for the PRIME Study.

Watch this video and visit our website to learn more and to submit your application: 
https://neuralink.com/patient-registry/

—

The PRIME Study (short for Precise Robotically Implanted Brain-Computer Interface) – a groundbreaking investigational medical device trial for our fully-implantable, wireless brain-computer interface (BCI) – aims to evaluate the safety of our implant and surgical robot, and assess the initial functionality of our BCI for enabling people with quadriplegia to control external devices with their thoughts.

This study involves placing a small, cosmetically invisible implant in a part of the brain that plans movements. The device is designed to interpret a person’s neural activity, so they can operate a computer or smartphone by simply intending to move – no wires or physical movement are required.

This research will be the first of its kind to be performed in people and may help us find safer, more effective ways to implant and use our BCI to potentially restore and enhance computer control and other capabilities.

—

Music: ‘Signal to Noise' by Scott Buckley - released under CC-BY 4.0.
https://www.scottbuckley.com.au